Name
aktsiaselts PMA
Registry code
10125062
Type
AS - Joint Stock Company
Status
Registered
Foundation date
16.09.1996 (28)
Financial year
01.01-31.12
Capital
25 520.00 €
Activity
86221 - Provision of specialised medical treatment
222 781 €
57 395 €
26%
2 538 €
(estimate is approximate)
248 345 €
3
Submitted
No tax arrears
23%
12%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Indrek Truija 23.12.1963 (60) | 100% - 25 520.00 EUR | Board member | Direct ownership | Shareholder |
| Jüri Kesküla 13.11.1964 (59) | - | - | - | Board member |
| Kristi Kõiv 09.04.1981 (43) | - | - | - | Board member |
| Külli Raup 07.05.1965 (59) | - | - | - | Chairman of the board |
| 2019 30.06.2020 | 2020 29.06.2021 | 2021 27.06.2022 | 2022 29.06.2023 | 2023 14.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 297 788 € | 286 236 € | 263 854 € | 195 517 € | 222 781 € |
| Net profit (loss) for the period | 82 213 € | 70 192 € | -1 435 080 € | 71 195 € | 57 395 € |
| Profit Margin | 28% | 25% | -544% | 36% | 26% |
| Current Assets | 1 178 759 € | 1 258 137 € | 379 591 € | 449 259 € | 482 658 € |
| Fixed Assets | 917 573 € | 923 244 € | 4 411 € | 3 151 € | 10 997 € |
| Total Assets | 2 096 332 € | 2 181 381 € | 384 002 € | 452 410 € | 493 655 € |
| Current Liabilities | 132 845 € | 128 532 € | 26 365 € | 23 577 € | 28 728 € |
| Non Current Liabilities | 459 834 € | 488 914 € | 234 882 € | 234 882 € | 216 582 € |
| Total Liabilities | 592 679 € | 617 446 € | 261 247 € | 258 459 € | 245 310 € |
| Share Capital | 25 520 € | 25 520 € | 25 520 € | 25 520 € | 25 520 € |
| Equity | 1 503 653 € | 1 563 935 € | 122 755 € | 193 951 € | 248 345 € |
| Employees | 3 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 11 251.59 € | 12 105.16 € | 4 |
| 2023 Q4 | - | 12 940.11 € | 13 383.35 € | 4 |
| 2023 Q3 | - | 12 979.24 € | 13 951.15 € | 4 |
| 2023 Q2 | - | 8 971.49 € | 9 668.12 € | 4 |
| 2023 Q1 | - | 9 267.88 € | 9 970.13 € | 4 |
| 2022 Q4 | - | 9 701.06 € | 10 415.14 € | 4 |
| 2022 Q3 | - | 9 142.39 € | 9 795.62 € | 4 |
| 2022 Q2 | - | 7 669.76 € | 8 211.75 € | 4 |
| 2022 Q1 | - | 10 884.18 € | 11 702.99 € | 4 |
| 2021 Q4 | - | 15 876.12 € | 15 616.58 € | 6 |
| 2021 Q3 | - | 14 510.68 € | 15 435.12 € | 6 |
| 2021 Q2 | - | 14 891.94 € | 14 089.61 € | 6 |
| 2021 Q1 | - | 15 441.77 € | 16 475.53 € | 6 |
| 2020 Q4 | - | 18 192.23 € | 19 392.42 € | 6 |
| 2020 Q3 | - | 15 613.6 € | 16 382.55 € | 6 |
| 2020 Q2 | - | 3 537.55 € | 3 537.55 € | 6 |
| 2020 Q1 | - | 16 039.82 € | 17 006.38 € | 6 |
